Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators aim to further the understanding of environmental factors that may underlie variations in body composition seen in youth with Type 1 diabetes (T1D). Non-caloric artificial sweeteners, broadly consumed in many individuals with T1D, are a modifiable dietary factor that may be associated with negative health outcomes, particularly those relevant to the future risk of diabetes-related complications.
Investigators will measure body composition (the amount of fat and muscle in the body and where the fat is stored) using a bioelectrical impedance analysis machine and DEXA scanner. Blood will be drawn for the following labs: HbA1c, lipid panel, comprehensive metabolic panel and leptin. Participants will also answer questions about their diets and consumption of artificial sweeteners.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Bioelectrical Impedance Analysis | Diagnostic Test | BIA is a radiation-free and clinically accessible measure of body composition [47, 49]. An electrode is placed on the youth's extremities and they are asked to sit for 10 minutes. The youth's height and weight is manually inputted and the measure is obtained (approx. 90 seconds to complete). BIA sends a low level of electrical current through the body and measures the impedance to the current based on fat, muscle, bones providing a measure of body composition. |
| |
| Total Body Dual-energy X-ray Absorptiometry | Diagnostic Test | The DXA total body scan provides measurements of percent body fat, lean and fat free mass throughout the body. Youth lay on a table while the machine moves around them. The process takes about 3 minutes and 20 seconds. |
| |
| Blood draw | Diagnostic Test | Blood will be drawn to assess the following labs: HbA1c, leptin, lipid panel and comprehensive metabolic panel. |
| Measure | Description | Time Frame |
|---|---|---|
| Quantify artificial sweetener consumption in youth with type 1 diabetes | To quantify artificial sweetener consumption patterns in a cohort of youth with T1D through novel food frequency questionnaires (Non-caloric artificial sweetener Food Frequency Questionnaire for Food and the Non-caloric artificial sweetener Food Frequency Questionnaire for Beverages) and bioassay | Study Duration (1 year) |
| Examine the relationship between artificial sweeteners and body composition | To characterize the relationship between artificial sweetener consumption and measures of body composition, as measured by bioelectrical impedance analysis and DXA scanning, which provide information on the amount and distribution of fat and muscle in the body. | Study Duration (1 year) |
| Examine the relationship between artificial sweeteners and kidney function | To determine if the level of artificial sweeteners is associated with the serum creatinine level. | Study Duration (1 year) |
| Examine the relationship between artificial sweeteners and liver function | To determine if the level of artificial sweeteners is associated with serum AST and ALT levels | Study Duration (1 year) |
| Examine the relationship between artificial sweeteners and lipid levels. | To characterize the relationship between artificial sweetener consumption and metabolism and the levels of fasting lipids (triglyceride level, HDL, LDL, and total cholesterol). | Study Duration (1 year) |
| Examine the relationship between artificial sweeteners and metabolism. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Youth receiving care at the Children's Hospital of Wisconsin Diabetes Clinic.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003922 | Diabetes Mellitus, Type 1 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D001800 | Blood Specimen Collection |
| ID | Term |
|---|---|
| D013048 | Specimen Handling |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood plasma will be used for metabolomic analyses. Samples will be stored and used until none is left.
To characterize the relationship between artificial sweetener consumption and metabolism, as measured by a leptin level.
| Study Duration (1 year) |
| Examine the relationship between artificial sweeteners and glycemic control | To characterize the relationship between artificial sweetener consumption and measures of glycemic control, as determined by the presence or absence of microalbuminuria. | Study Duration (1 year) |
| Examine the relationship between artificial sweeteners and glycemic control | To characterize the relationship between artificial sweetener consumption and measures of glycemic control, as measured by total daily insulin dose. | Study Duration (1 year) |
| Examine the relationship between artificial sweeteners and glycemic control | To characterize the relationship between artificial sweetener consumption and measures of glycemic control, as measured by the percentage of time participants are within ideal range for blood glucose levels (as measured by glucose monitors.) | Study Duration (1 year) |
| Examine the relationship between artificial sweeteners and hemoglobin A1c | To characterize the relationship between artificial sweetener consumption and measures of glycemic control, as measured by serum HbA1c. | Study Duration (1 year) |
| D004700 | Endocrine System Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D011677 | Punctures |
| D013514 | Surgical Procedures, Operative |
| D008919 | Investigative Techniques |